ProKidney Corp.
ProKidney Corp.（PROK）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
prok · 股价预测 · 8 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 8 位华尔街分析师
Buy
8 位分析师
共识
评级分布
12 个月目标价
High
$6.00
Consensus
$4.67
+173.1% upside
Low
$3.00
Median: $5 · Last Close: $1.71
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$4.67
173.1% upside
High Target
$6
250.9%
Low Target
$3
75.4%
Current Price
$1.71
as of today
Based on analyst price targets, the PROK stock price prediction for the next 12 months ranges from $3 to $6. The consensus PROK price forecast of $4.67 implies 173.1% upside from the current price of $1.71.
短期股价预测
Bear算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $1.75 | ↑ 2.31% |
1-day model range: $1.73–$1.77. Peak: $1.77 (+2.31%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · PROK · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-07-15 | UBS | Maintains | Buy→Buy |
| 2025-07-14 | Guggenheim | Maintains | Buy→Buy |
| 2025-07-09 | Citigroup | Maintains | Buy→Buy |
| 2025-06-30 | B of A Securities | Downgrade ↓ | Neutral→Underperform |
| 2024-09-04 | B of A Securities | Maintains | Neutral→Neutral |
| 2024-06-10 | Jefferies | Maintains | Buy→Buy |
| 2024-05-29 | B of A Securities | Maintains | Neutral→Neutral |
| 2024-01-02 | B of A Securities | Downgrade ↓ | Buy→Neutral |
| 2022-12-21 | Jefferies | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on ProKidney Corp. (PROK) stock. Of the recent 14 rating actions, 0 were upgrades and 2 were downgrades. 8 analysts currently cover PROK.
分析师推荐趋势
PROK analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$1M
↓ 99.1% YoY
Revenue Next Year
$0M
↓ 12.0% YoY
EPS This Year
$-0.64
EPS Next Year
$-0.66
↑ 2.9% YoY
EPS ForecastReported vs Estimated
Analysts forecast PROK EPS of $-0.64 for the current fiscal year, based on estimates from 3 analysts. The PROK revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
PROK 股价预测由两类独立数据源支撑：来自 8 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。PROK 的共识目标价为 $4.67（+173.1% 上行空间），分析师共识为 Buy。
PROK 的短期预测（明日）为 $1.75（+2.31%）。
ProKidney Corp. 在 NASDAQ 上市，代码 PROK。PROK 在 2027 年的整体展望偏积极，在覆盖分析师中约 75% 对应 Buy 共识。
常见问题
PROK 预测 · 8 个问题根据 8 位华尔街分析师，PROK 的 12 个月平均目标价为 $4.67，最高 $6.00、最低 $3.00。若有图表，中位目标价可在上方查看。相对当前价 $1.71，隐含约 +173.1% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.